NewAmsterdam Pharma Co. NV (NAMS)
36.20
+0.60
(+1.67%)
USD |
NASDAQ |
Dec 11, 16:00
36.20
0.00 (0.00%)
After-Hours: 19:02
NewAmsterdam Pharma Total Liabilities (Quarterly): 58.36M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 659.64M |
| ProQR Therapeutics NV | 79.05M |
| Merus NV | 129.26M |
| argenx SE | -- |
| Pharming Group NV | 209.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 786.43M |
| Shareholders Equity (Quarterly) | 728.07M |
| Debt to Equity Ratio | 0.0004 |
| Current Ratio | 12.57 |
| Net Debt Paydown Yield | 0.00% |